Vivos (RDGL) Current Leases (2010 - 2025)

Vivos (RDGL) posted Current Leases of $25420.0 for Q4 2025, down 35.61% sequentially from $39481.0 in Q4 2014.

Vivos (RDGL) Current Leases (2010 - 2025) Analysis & Trends

Vivos has reported Current Leases for 6 years, with the latest figure at $25420.0 in Q4 2025.

Quarterly Current Leases changed N/A year-over-year to $25420.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $25420.0 (changed N/A YoY) and the FY2025 annual result came in at $25420.0, changed N/A from the prior year.
Current Leases declined to $25420.0 in Q4 2025 per RDGL's latest filing, from $39481.0 in the prior quarter.
Over five years, Current Leases peaked at $25420.0 in Q4 2025 and troughed at $25420.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Abbott Laboratories	199.61 Bn	194.01 Bn	7.27 Bn	-
2	Stryker	127.81 Bn	124.34 Bn	4.50 Bn	-
3	Medtronic	119.04 Bn	109.82 Bn	6.41 Bn	-
4	Boston Scientific	73.68 Bn	73.14 Bn	3.85 Bn	-
5	Edwards Lifesciences	51.96 Bn	47.71 Bn	1.35 Bn	24.10 Mn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn	20.70 Mn
7	GE HealthCare Technologies	33.83 Bn	31.72 Bn	2.18 Bn	-
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	-
9	Steris	23.06 Bn	22.58 Bn	684.20 Mn	35.60 Mn
10	Vivos	24.90 Mn	23.34 Mn	-3,105.00	25,420.00

Download Data